Skip to content
SWOI media

Europe risks returning to ‘pre-antibiotic era’ amid growing threat of drug-resistant superbugs

← Back to News

Europe risks returning to ‘pre-antibiotic era’ amid growing threat of drug-resistant superbugs

By Marta Iraola IribarrenSource: Euronews RSSen5 min read
Europe risks returning to ‘pre-antibiotic era’ amid growing threat of drug-resistant superbugs

Antibiotic resistance is rising across Europe, with some countries facing sharper increases and fewer treatment options as experts call for stronger prevention and more responsible antibiotic use.

Resistance to antibiotics remains a major health threat in Europe, with infections caused by drug-resistant superbugs surging in some countries, the European Centre for Disease Prevention and Control (ECDC) warned on Wednesday, highlighting the growing threat to the effectiveness of available treatments.

Every year, over 35,000 people die from antimicrobial resistance (AMR) in the European Union, Iceland, Liechtenstein and Norway — comparable to the combined mortality of influenza, tuberculosis and HIV.

Growing resistance is leaving doctors with fewer treatment options, Christian Giske, head of ECDC’s Antimicrobial Resistance and Healthcare-Associated Infections Section, told reporters on Tuesday, stressing the need for urgent action to safeguard the effectiveness of antibiotics.

“Without effective antibiotics, we could return to the ‘pre-antibiotic era’, and it would be difficult, if not impossible, to safely perform organ transplantation, cancer chemotherapy, ensure intensive care or other medical procedures,” the ECDC report warned.

Antimicrobial resistance occurs when microorganisms, such as bacteria, develop the ability to withstand the drugs designed to kill them or stop their growth.

Despite longstanding efforts to reduce antibiotic use and tackle resistance, new ECDC data show that the situation is worsening as new bacterial strains are emerging that are resistant to several antibiotics at the same time. These are known as multidrug-resistant bacteria.

The European health agency has identified bloodstream infections caused by resistant bacteria as a particular concern, with the region lagging behind its reduction targets, particularly for Klebsiella pneumoniae and Escherichia coli (E. coli), which are associated with high patient mortality rates.

The estimated EU incidence of antibiotic-resistant E. coli infections grew by 16.4% between 2019 and 2025, despite a target to achieve a 10% reduction from the 2019 baseline.

K. pneumoniae — a bacterium that commonly causes urinary tract, respiratory tract and bloodstream infections — is another major concern for the ECDC.

“We can also see not only that many of the strains are related, suggesting that there is indeed strain transmission, but we can see that they are increasingly getting very difficult to treat because of their mechanisms of resistance,” Giske said.

The target is to reduce K. pneumoniae infections by 5% from the 2019 baseline. However, in 2025, the incidence stood at 3.75 cases per 100,000 people, representing a 72% increase compared with that baseline.

Which countries are struggling the most?

While antibiotic resistance is a challenge across Europe, AMR levels and antibiotic consumption vary widely among countries.

Cyprus has seen a 716% surge in antibiotic-resistant K. pneumoniae infections, reaching 21.29 cases per 100,000 people last year, the report found. It has also seen a 276% increase in antibiotic-resistant E. coli bloodstream infections.

For K. pneumoniae, Romania follows with 18.66 antibiotic-resistant infections per 100,000 population and Greece with 16.28 per 100,000 people.

The ECDC is also concerned about the steep increases recorded in recent years, particularly in Hungary, where resistant K. pneumoniae infections rose by 1,622%. Croatia recorded a 409% increase and Bulgaria a 356% rise.

How can Europe tackle growing antibiotic resistance?

Giske noted that addressing the growing threat of resistance requires action on two fronts: preventing infections and controlling antimicrobial use.

More than 70% of the health burden of antimicrobial resistance in Europe is attributable to healthcare-associated infections involving multidrug-resistant bacteria — for example, when patients are infected while hospitalised. Half of this burden could be prevented through stronger infection prevention and control measures, according to the ECDC.

“There are some measures that can be done at the point of care that pertain to hand hygiene and protective equipment, but also to placement of infected patients in single rooms and, additionally, to effective environmental cleaning,” Giske said.

Action is also needed at the healthcare system level, including ensuring appropriate staffing for infection prevention and control, providing access to suitable laboratory diagnostics and improving surveillance of resistant bacteria, he added.

“Infection prevention and control is about preventing infections and thus stopping the spread of bacteria, while antimicrobial stewardship is about using antibiotics wisely,” Giske added.

But tackling resistance is not just about how many antibiotics are used; it also depends on which ones are prescribed and how they are used.

Antibiotics continue to be prescribed or used inappropriately for viral infections — such as colds, influenza and COVID-19 — for which they offer no therapeutic benefit, the ECDC warned. This unnecessary exposure puts selective pressure on bacteria, allowing resistant strains to survive and spread.

The ECDC also noted that approximately 90% of total human antibiotic consumption takes place in outpatient or community settings.

Infants and preschool-aged children, for example, are frequently given unnecessary antibiotics for viral coughs, colds and sore throats that could resolve on their own, the agency noted.

Preventing infections outside healthcare facilities is also important. Giske cited good hand hygiene and vaccination, which can reduce the need for hospitalisation and antibiotic use overall.

“There are also things that can be done beyond healthcare facilities and system level, and these are some aspects that pertain specifically to the community setting,” Giske said.

Tags

NOGRHUROBGHRTechnologyEnvironmentSocietyInternational

Discussion

Sign In to join the discussion

Loading...

Related Articles